BioMarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU).
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of BMRN would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1999) — listing | $100,314 2.5× | $145,725 2.5× |
| Year 6 (2004) | $64,555 1.9× | $93,683 1.9× |
| Year 11 (2009) | $27,110 1.0× | $39,364 1.0× |
| Year 16 (2014) | $12,091 0.6× | $17,571 0.6× |
| Year 21 (2019) | $7,557 0.7× | $10,988 0.7× |
| Year 26 (2024) | $2,914 0.8× | $4,261 0.8× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
San Rafael, California, United States
Popular scenarios with BMRN
For illustration only — not investment advice. Past performance is not indicative of future results.